Fondazione Sisa (societa Italiana Per Lo Studio Della Arteriosclerosi)

This study looks at whether adding the drug evinacumab to standard cholesterol treatment can reduce or slow the buildup of plaque in the arteries of people with homozygous familial hypercholesterolemia (HoFH), a rare genetic condition causing extremely high cholesterol. About 52 …